|
22 Jan 2020 |
Ocuphire Pharma Announces In-License of Phase 2 Oral Small Molecule Drug Candidate for Diabetic Retinopathy and Diabetic Macular Edema from Apexian Pharmaceuticals
|
|
21 Jan 2020 |
Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes
|
|
21 Jan 2020 |
PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical
|
|
17 Jan 2020 |
Syndivia In-Licenses Novel Antibody Against Tumor-Specific Form of CD146 From SATT Sud-Est
|
|
17 Jan 2020 |
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
|
|
16 Jan 2020 |
Fibrocor and Galapagos sign expanded collaboration in fibrosis
|
|
15 Jan 2020 |
Artisan Bio Announces Global Research and Discovery Collaboration Agreement with Takeda to Develop Next-Generation Cell Therapy Products
|
|
15 Jan 2020 |
Dermavant Enters into Exclusive License Agreement with JT for Development and Commercialization of Tapinarof in Japan
|
|
14 Jan 2020 |
Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies
|
|
14 Jan 2020 |
Allele and Astellas Enter into an Expanded License for the Development of iPSC Lines
|
|
13 Jan 2020 |
Editas Medicine and Sandhill Therapeutics, Inc. Announce Collaboration to Develop Engineered Cell Medicines to Treat Cancer
|
|
13 Jan 2020 |
Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular degeneration (AMD) and Diabetic Macular Oedema (DMO)
|
|
13 Jan 2020 |
Fauna Bio and Novo Nordisk enter into Research Collaboration to Discover Novel Therapeutics for Obesity
|
|
13 Jan 2020 |
Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences
|
|
13 Jan 2020 |
Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
|
|
13 Jan 2020 |
CNS Pharmaceuticals Licenses Breakthrough Technology from MD Anderson, Doubling its Drug Pipeline
|
|
13 Jan 2020 |
Charles River and Takeda Announce Scientific Collaboration to Identify and Develop Preclinical Candidates
|
|
13 Jan 2020 |
Iovance Biotherapeutics Obtains License to Develop and Commercialize a Novel IL-2 Analog
|
|
13 Jan 2020 |
Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement
|
|
13 Jan 2020 |
Bayer and Daré Bioscience enter into exclusive license agreement for U.S. commercial rights to investigational hormone-free, monthly contraceptive Ovaprene®
|
|
13 Jan 2020 |
Biogen to Acquire Novel Clinical Stage Asset with Application in Alzheimer’s Disease and Parkinson’s Disease from Pfizer Inc.
|
|
13 Jan 2020 |
MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab (news with additional features)
|
|
12 Jan 2020 |
Serimmune and Atreca, Inc. Establish Research Collaboration Agreement in Oncology
|
|
12 Jan 2020 |
Chinook Therapeutics Obtains Worldwide Rights from AbbVie to Atrasentan with Plans to Develop for the Treatment of Kidney Diseases
|
|
12 Jan 2020 |
Amunix Pharmaceuticals Announces Technology Licensing Agreement with Roche to Advance Novel Therapeutics Outside Oncology
|
